Cost-utility analysis of the DREAMS START intervention for people living with dementia and their carers: a within-trial economic evaluation.
Gonzalez L. et al, (2025), Lancet Healthy Longev, 6
Prevalence Rates of Frequent Dream Recall and Nightmares by Age, Gender and Sleep Duration in 16 Countries.
Bolstad CJ. et al, (2025), J Sleep Res
Sleep During Pandemic Times: Summary of Findings and Future Outlook Through the Lens of the International COVID Sleep Study (ICOSS).
Bjorvatn B. et al, (2025), J Sleep Res
Emotional Processing Following Digital Cognitive Behavioral Therapy for Insomnia in People With Depressive Symptoms: A Randomized Clinical Trial.
Tamm S. et al, (2025), JAMA Netw Open, 8
The Sleep Condition Indicator (SCI): Psychometric properties of the European Portuguese version.
Marques DR. et al, (2024), J Sleep Res
Associations between obesity, a composite risk score for probable long COVID, and sleep problems in SARS-CoV-2 vaccinated individuals.
Xue P. et al, (2024), Int J Obes (Lond)
Restless legs symptoms increased during COVID-19 pandemic. International ICOSS-survey.
Partinen E. et al, (2024), Sleep Med, 119, 389 - 398
The effect of single-component sleep restriction therapy on depressive symptoms: A systematic review and meta-analysis.
Tse KYK. et al, (2024), J Sleep Res
Nightmare frequency is a risk factor for suicidal ideation during the COVID-19 pandemic.
Bolstad CJ. et al, (2024), J Sleep Res
Nurse-delivered sleep restriction therapy in primary care for adults with insomnia disorder: a mixed-methods process evaluation.
Armstrong S. et al, (2024), Br J Gen Pract, 74, e34 - e40
The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023.
Riemann D. et al, (2023), J Sleep Res, 32
Associations between changes in habitual sleep duration and lower self-rated health among COVID-19 survivors: findings from a survey across 16 countries/regions.
Matsui K. et al, (2023), BMC Public Health, 23